Search Orphan Drug Designations and Approvals
Return to Orphan Designation Search Page
|Generic Name:||recombinant human monoclonal antibody against activin receptors type II|
|Orphan Designation:||Treatment of inclusion body myositis|
|Orphan Designation Status:||Designated|
|FDA Orphan Approval Status:||Not FDA Approved for Orphan Indication|
Novartis Pharmaceuticals Corp.
One Health Plaza
East Hanover, New Jersey 07936
The sponsor address listed is the last reported by the sponsor to OOPD.